From May 21-23, 2025, Lei Haichao, Director of the National Health Commission of the P.R.C, led a delegation on an official visit to France.

Point-of-care testing (POCT) is a subfield of in vitro diagnostics (IVD), where portable analytical instruments and supporting reagents are used to obtain test results quickly at the sampling site.

MA activity in the liquid biopsy space is picking up as Bio-Techne said it will acquire Exosome Diagnostics for $250 million plus $325 million in potential milestones. Waltham, MA-based Exosome has developed the urine-based test ExoDx Prost

President Donald Trump is trying to shame the largest U.S. drugmaker for hikingpricesafter he earlier said industry players were planning massive price reductions. He said Pfizer and others should be ashamed that they have raised drug price

The global molecular diagnostics market is expected to grow at a CAGR of8.4% from USD 7.71 billion in 2018 to USD 11.54 billion by 2023, driven by theincreasing prevalence of infectious diseases and various types of cancers,rising awareness

Video-assisted lobectomies performed withpowered staplers resulted in nearly half as many patient bleeding complicationsas those conducted with manual staplers, according to a recent study. Patients treated with powered staplers wererelease

Medtronic topped estimates in its latestearnings, fueled by sales from valves and diabetes products. For theDublin-based companys 4Q18 earnings it brought in about $8.14 billion, a 6.5percent increase. The firms Cardiac and Vascular group (

The National Institutes of Healths All ofUs Research Program issued a funding announcement today for Genome Centers togenerate genotype and whole-genome sequence data from the samples submitted byparticipants in the program. The information

The Association of Community Cancer Centers(ACCC), a cancer care provider advocacy group, announced today that Pfizer willprovide $1.5 million in grant funding to support initiatives integrating BRCAtesting into patient care plans.

​ 绿叶生命科学集团旗下Vela Diagnostics表示，中国食品药物监督管理总局已批准其Sentosa SX游离DNA试剂盒。 该试剂盒旨在从血浆中提取血浆游离循环DNA，并开发用于RT-PCR和第二代基因测序

据市场研究和咨询公司Coherent Market Insights的最新报告，美国全球聚合酶链式反应市场（PCR）2017年价值37亿美元，预计到2025年，预测期内（2017-2025）的复合年增长率将达8.8％，超过74亿美